Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiography, Dual-Energy Scanned Projection | 1 | 2018 | 5 | 0.690 |
Why?
|
Practice Management, Medical | 1 | 2018 | 9 | 0.680 |
Why?
|
Cerebrospinal Fluid | 1 | 2018 | 12 | 0.670 |
Why?
|
Orbit | 1 | 2018 | 14 | 0.660 |
Why?
|
Dermoid Cyst | 1 | 2015 | 2 | 0.540 |
Why?
|
Ovary | 1 | 2015 | 53 | 0.520 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 858 | 0.500 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 1144 | 0.490 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 532 | 0.390 |
Why?
|
Neoplasms | 1 | 2015 | 596 | 0.350 |
Why?
|
Mass Spectrometry | 3 | 2015 | 95 | 0.290 |
Why?
|
Anopheles | 1 | 2004 | 1 | 0.250 |
Why?
|
Insect Vectors | 1 | 2004 | 3 | 0.250 |
Why?
|
Malaria | 1 | 2004 | 10 | 0.250 |
Why?
|
Software | 3 | 2018 | 106 | 0.240 |
Why?
|
Proteomics | 2 | 2015 | 86 | 0.220 |
Why?
|
Peptides | 3 | 2006 | 116 | 0.200 |
Why?
|
Humans | 12 | 2018 | 28304 | 0.200 |
Why?
|
Ultrasonography | 2 | 2015 | 347 | 0.180 |
Why?
|
Animals | 11 | 2015 | 6402 | 0.180 |
Why?
|
Workflow | 1 | 2018 | 17 | 0.170 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 40 | 0.170 |
Why?
|
Infant, Newborn | 2 | 2018 | 587 | 0.170 |
Why?
|
Hypoglycemic Agents | 2 | 2018 | 177 | 0.160 |
Why?
|
Telemedicine | 1 | 2018 | 72 | 0.150 |
Why?
|
Decision Making | 1 | 2018 | 154 | 0.150 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 436 | 0.140 |
Why?
|
Maximum Tolerated Dose | 1 | 2015 | 55 | 0.140 |
Why?
|
Clinical Competence | 1 | 2018 | 296 | 0.140 |
Why?
|
Nerve Growth Factors | 1 | 2015 | 15 | 0.140 |
Why?
|
Infant | 1 | 2018 | 928 | 0.130 |
Why?
|
Age Factors | 1 | 2018 | 1058 | 0.130 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 95 | 0.130 |
Why?
|
Child, Preschool | 1 | 2018 | 1126 | 0.130 |
Why?
|
Proteins | 2 | 2006 | 142 | 0.130 |
Why?
|
C-Reactive Protein | 1 | 2015 | 236 | 0.130 |
Why?
|
Gene Expression Profiling | 2 | 2007 | 323 | 0.120 |
Why?
|
Thiazolidinediones | 2 | 2006 | 47 | 0.120 |
Why?
|
Climate Change | 1 | 2013 | 3 | 0.120 |
Why?
|
Carbon | 1 | 2013 | 9 | 0.120 |
Why?
|
Social Responsibility | 1 | 2013 | 13 | 0.120 |
Why?
|
Female | 5 | 2018 | 17679 | 0.120 |
Why?
|
Retrospective Studies | 2 | 2018 | 2930 | 0.110 |
Why?
|
Skull Fractures | 1 | 2012 | 16 | 0.110 |
Why?
|
Parietal Bone | 1 | 2012 | 11 | 0.110 |
Why?
|
Child | 1 | 2018 | 2151 | 0.110 |
Why?
|
Alzheimer Disease | 1 | 2015 | 291 | 0.110 |
Why?
|
Prognosis | 1 | 2015 | 1342 | 0.100 |
Why?
|
Male | 7 | 2018 | 16967 | 0.100 |
Why?
|
Intensive Care Units | 1 | 2012 | 116 | 0.100 |
Why?
|
Sepsis | 1 | 2012 | 145 | 0.100 |
Why?
|
Algorithms | 4 | 2010 | 456 | 0.090 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2010 | 4 | 0.090 |
Why?
|
Receptors, Calcitonin Gene-Related Peptide | 1 | 2008 | 1 | 0.080 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2008 | 2 | 0.080 |
Why?
|
Substance P | 1 | 2008 | 20 | 0.080 |
Why?
|
Treatment Outcome | 1 | 2015 | 2886 | 0.080 |
Why?
|
TRPV Cation Channels | 1 | 2008 | 17 | 0.080 |
Why?
|
Kidney Pelvis | 1 | 2008 | 21 | 0.080 |
Why?
|
Neurons, Afferent | 1 | 2008 | 33 | 0.080 |
Why?
|
Models, Biological | 2 | 2007 | 356 | 0.080 |
Why?
|
Arteries | 1 | 2008 | 61 | 0.080 |
Why?
|
Ganglia, Spinal | 1 | 2008 | 59 | 0.080 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 69 | 0.080 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2006 | 4 | 0.080 |
Why?
|
Complex Mixtures | 1 | 2006 | 3 | 0.080 |
Why?
|
Proteome | 1 | 2007 | 30 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 23 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2008 | 229 | 0.070 |
Why?
|
Chromatography, Liquid | 1 | 2004 | 40 | 0.060 |
Why?
|
Sequence Alignment | 1 | 2004 | 60 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2004 | 22 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2004 | 32 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 147 | 0.060 |
Why?
|
Young Adult | 3 | 2018 | 2321 | 0.060 |
Why?
|
Rats | 4 | 2008 | 1425 | 0.060 |
Why?
|
Signal Transduction | 1 | 2007 | 607 | 0.060 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 14 | 0.050 |
Why?
|
Trans-Activators | 1 | 2002 | 47 | 0.050 |
Why?
|
Adult | 4 | 2018 | 8243 | 0.050 |
Why?
|
Adipocytes | 1 | 2002 | 81 | 0.050 |
Why?
|
Transcription Factors | 1 | 2002 | 175 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2002 | 467 | 0.040 |
Why?
|
Specimen Handling | 1 | 2018 | 28 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2010 | 268 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2010 | 340 | 0.040 |
Why?
|
Middle Aged | 3 | 2018 | 10678 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2015 | 3562 | 0.040 |
Why?
|
Mice | 3 | 2007 | 2181 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2010 | 480 | 0.030 |
Why?
|
Time Factors | 2 | 2012 | 1874 | 0.030 |
Why?
|
Ecosystem | 1 | 2013 | 5 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2006 | 700 | 0.030 |
Why?
|
Patient Admission | 1 | 2012 | 51 | 0.030 |
Why?
|
Aged | 2 | 2015 | 9256 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2012 | 180 | 0.020 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2010 | 3 | 0.020 |
Why?
|
Oligopeptides | 1 | 2010 | 47 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 77 | 0.020 |
Why?
|
Survival Rate | 1 | 2012 | 775 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2010 | 133 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2010 | 390 | 0.020 |
Why?
|
Incidence | 1 | 2012 | 1087 | 0.020 |
Why?
|
Isoindoles | 1 | 2008 | 6 | 0.020 |
Why?
|
Quinuclidines | 1 | 2008 | 3 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2008 | 8 | 0.020 |
Why?
|
Capsaicin | 1 | 2008 | 20 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2008 | 73 | 0.020 |
Why?
|
Radio Waves | 1 | 2008 | 5 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2008 | 59 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2008 | 89 | 0.020 |
Why?
|
Peptide Mapping | 1 | 2006 | 2 | 0.020 |
Why?
|
Hemodynamics | 1 | 2008 | 158 | 0.020 |
Why?
|
Taurine | 1 | 2006 | 3 | 0.020 |
Why?
|
Multigene Family | 1 | 2007 | 49 | 0.020 |
Why?
|
Solutions | 1 | 2006 | 25 | 0.020 |
Why?
|
Muramidase | 1 | 2006 | 9 | 0.020 |
Why?
|
Protons | 1 | 2006 | 22 | 0.020 |
Why?
|
Models, Statistical | 1 | 2008 | 157 | 0.020 |
Why?
|
Cattle | 1 | 2006 | 97 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2006 | 81 | 0.020 |
Why?
|
Computer Simulation | 1 | 2007 | 187 | 0.020 |
Why?
|
Genetic Variation | 1 | 2007 | 278 | 0.020 |
Why?
|
Genotype | 1 | 2007 | 813 | 0.020 |
Why?
|
Programming Languages | 1 | 2004 | 2 | 0.020 |
Why?
|
Systems Integration | 1 | 2004 | 6 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2004 | 36 | 0.020 |
Why?
|
Adolescent | 1 | 2012 | 3184 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2004 | 122 | 0.020 |
Why?
|
Documentation | 1 | 2004 | 32 | 0.020 |
Why?
|
Blood Pressure | 1 | 2008 | 861 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 521 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 2002 | 2 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 13 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2002 | 10 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2002 | 33 | 0.010 |
Why?
|
Thiazoles | 1 | 2002 | 30 | 0.010 |
Why?
|
beta Catenin | 1 | 2002 | 37 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 236 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2002 | 161 | 0.010 |
Why?
|
RNA | 1 | 2002 | 83 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2002 | 102 | 0.010 |
Why?
|
Blotting, Western | 1 | 2002 | 265 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2002 | 498 | 0.010 |
Why?
|
Phenotype | 1 | 2002 | 653 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2002 | 619 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2002 | 779 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2002 | 430 | 0.010 |
Why?
|